Activated Ketone Based Inhibitors of Human Renin

Journal of Medicinal Chemistry

Volumn 36, Issue 17, 1993, Pages 2431-2447

  Patel, Dinesh V ^a   Rielly Gauvin, Katherine ^a   Ryono, Denis E ^a   Free, Charles A ^a   Smith, Sandra A ^a   Petrillo, Edward W ^a  

^a BRISTOL MYERS SQUIBB PHARMACEUTICAL RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,2 DICARBONYL DERIVATIVE; KETONE DERIVATIVE; RENIN; RENIN INHIBITOR;

ARTICLE; DRUG POTENCY; DRUG SYNTHESIS; ENZYME INHIBITION; HUMAN; HYDRATION; PRIORITY JOURNAL;

EID: 0027172371     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm00069a001     Document Type: Article

References (63)

1. Petrillo, E. W., Jr.; Ondetti, M. A. Angiotensin-Converting Enzyme Inhibitors: Medicinal Chemistry and Biological Actions. Med. Res. Rev. 1982, 2, 1–38.
2. For a review of early work on renin inhibitors, see:Greenlee, W. J. Renin Inhibitors. Med. Res. Rev. 1990, 10, 173–226.
3. 4 Tripeptide Portion of the Angiotensinogen Template. J. Med. Chem. 1991, 34, 1276–1282.
4. Ashton, W. T.; Cantone, C. L.; Tolman, R. L.; Greenlee, W. J.; Lynch, R. J.; Schorn, T. W.; Strouse, J. F.; Siegl, P. K. S. Inhibitors of Human Renin with C-Termini Derived from Amides and Esters of α-Mercaptoalkanoic Acids. J. Med. Chem. 1992, 35, 2772–2781.
5. Doherty, A. M.; Sircar, I.; Kornberg, B. E.; Quin, J., III; Winters, R. T.; Raitenbronn, J. S.; Taylor, M. D.; Batley, B. L.; Rapundalo, S. R.; Ryan, M. J.; Painchaud, C. A. Design and Synthesis of Potent, Selective, and Orally Active Fluorine-Containing Renin Inhibitors. J. Med. Chem. 1992, 35, 2–14.
6. Kleinert, H. D.; Rosenberg, S. H.; Baker, W. R.; Stein, H. H.; Klinghofer, V.; Barlow, J.; Spina, R.; Polakowski, J.; Kovar, P.; Cohen, J.; Dennisen, J. Discovery of a Peptide-Based Renin Inhibitor with Oral Bioavailability and Efficacy. Science 1992, 257, 1940–1943.
7. Barrett, A. J.; Salvesen, G. Eds. Proteinase Inhibitors; Research monographs in cell and tissue physiology; Dingle, J. T., Gordon, J. L., General Eds.; Elsevier Science Publishers: Amsterdam, The Netherlands, 1986.
8. Gelb, M. H.; Svaren, J. P.; Abeles, R. H. Fluoro Retone Inhibitors of Hydrolytic Enzymes. Biochemistry 1985, 24, 1813–1817.
9. Kokubu, T.; Hiwada, R.; Nagae, E.; Murakami, E.; Morisawa, Y.; Yabe, Y.; Roike, H.; Iijima, Y. Statine-Containing Dipeptide and Tripeptide Inhibitors of Human Renin. Hypertension, 1986, 8 (suppl II), II–1-II-5.
10. Bolis, G.; Fung, A. R. L.; Greer, J.; Kleinert, H. D.; Marcotte, P. A.; Perun, T. J.; Plattner, J. J.; Stein, H. H. Renin Inhibitors. Dipeptide Analogues of Angiotensinogen Incorporating Transition-State, Nonpeptidic Replacements at the Scissile Bond. J. Med. Chem. 1987, 30, 1729–1737.
11. Rempf, D. J.; Lara, E.; Stein, H. H.; Cohen, J.; Plattner, J. J. Renin Inhibitors Based on Novel Dipeptide Analogues. Incorporation of the Dehydrohydroxyethylene Isostere at the Scissile Bond. J. Med. Chem. 1987, 30, 1978–1983.
12. Dellaria, J. F.; Maki, R. G.; Bopp, B. A.; Cohen, J.; Kleinert, H. D.; Luly, J. R.; Merits, L; Plattner, J. J.; Stein, H. H. Optimization and In Vivo Evaluations of a Series of Small, Potent, and Specific Renin Inhibitors Containing a Novel Leu-Val Replacement. J. Med. Chem. 1987, 30, 2137–2144.
13. Boger, J.; Payne, L. S.; Perlow, D. S.; Lohr, N. S.; Poe, M.; Blaine, E. H.; Ulm, E. H.; Schorn, T. W.; Lamont, B.; Lin, T. Y.; Kawai, M.; Rich, D. H.; Veber, D. F. Renin Inhibitors. Syntheses of Subnanomolar, Competitive, Transition-State Analogue Inhibitors Containing a Novel Analogue of Statine. J. Med. Chem. 1985, 28, 1779–1790.
14. The Weinreb amide 1 is extremely stable and can be safely stored at room temperature. The procedure for preparing aldehyde 2 via the stable Weinreb amide was developed by Dr. Harold Weiler. For similar synthesis of various α-amino aldehydes, see: (a)Fehrentz, J.-A.; Castro, B. An Efficient Synthesis of Optically Active-α-(t-Butoxycarbonylamino)-aldehydes from α-Amino Acids. Synthesis 1983, 676–678
15. Saari, W. S.; Fisher, T. E. A Convenient and Versatile Synthesis of Chiral Aliphatic and Allylic Amines. Synthesis 1990, 453–454
16. For alternate preparations of α-amino aldehyde 2, see ref 9 and the following: (a)Bock, M. G.; Dipardo, R. M.; Evans, B. E.; Freidinger, R. M.; Rittle, K. E.; Payne, L. S.; Boger, J.; Whitter, W. L.; LaMont, B. I.; Ulm, E. H.; Blaine, E. H.; Schorn, T. W.; Veber, D. F. Renin Inhibitors Containing Hydrophilic Groups. Tetrapeptides with Enhanced Aqueous Solubility and Nanomolar Potency. J. Med. Chem. 1988, 31, 1918–1923.
17. Luly, J. R.; Dellaria, J. F.; Plattner, J. J.; Soderquist, J. L.; Yi, N. A Synthesis of Protected Aminoalkyl Epoxides from α-Amino Acids. J. Org. Chem. 1987, 52, 1487–1492.
18. For preparation of configurationaly stable N-protected α-amino aldehydes, see:Lubell, W. D.; Rapoport, H. Configurational Stability of N-Protected α-Amino Aldehydes. J. Am. Chem. Soc. 1987, 109, 236–239.
19. For a preliminary communication on the preparation of fluoro ketone 11, see:Patel, D. V.; Rielly-Gauvin, K.; Ryono, Denis, E. Peptidic Trifluoromethyl Alcohols and Ketones. A General Synthesis and Application as Renin Inhibitors. Tetrahedron Lett. 1988, 29, 4665–4668.
20. Imperiali, B.; Abeles, R. H. A Versatile Synthesis of Peptidyl Fluoromethyl Ketones. Tetrahedron Lett. 1986, 27, 135–138.
21. Bergeson, S. H.; Edwards, P. D.; Krell, R. D.; Shaw, A.; Stein, R. L.; Stein, M. M.; Strimpler, A. M.; Trainor, D. A.; Wildonger, R. A.; Wolanin, D. J. Inhibition of Human Leukocyte Elastase by Peptide Trifluoromethyl Ketones. In Abstracts of Papers; 193rd National Meeting of the American Chemical Society, Denver, Colorado, April 5–10, 1987; American Chemical Society: Washington DC, 1987; MEDI 0001.
22. 3CHO. J. Chem. Educ. 1975, 52, 131.
23. Shioiri, T.; Ninomiya, K.; Yamada, S-I. Diphenylphosphoryl Azide. A New Convenient Reagent for a Modified Curtius Reaction and for the Peptide Synthesis. J. Am. Chem. Soc. 1972, 94, 6203–6205.
24. 1 Oxidant for the Conversion of Primary and Secondary Alcohols to Aldehydes and Ketones. J. Org. Chem. 1983, 48, 4155–4156.
25. Dess-Martin oxidation is one of the best methods available for oxidation of alcohols bearing electron-deficient groups to the corresponding activated ketones. For the first application of this reagent toward the preparation of trifluoromethyl ketones, see: (a)Linderman, R. J.; Graves, D. M. An Efficient Procedure for the Oxidation of Fluorinated Carbinols. Tetrahedron Lett. 1987, 28, 4259–4262. For a detailed account, see
26. Linderman, R. J.; Graves, D. M. Oxidation of Fluoroalkyl-Substituted Carbinols by the Dess-Martin Reagent. J. Org. Chem. 1989, 54, 661–668.
27. Charles, I.; Latham, D. W. S.; Hartley, D.; Oxford, A. W.; Scopes, D. I. C. Bicyclic Heterocycles with Nitrogen at the Ring Junction. Part 2. Application of the Dakin-West Reaction to the Synthesis of Imidazo-[5,1-f]-1,2,4-[triazin-4(3H)-ones. J. Chem. Soc., Perkin Trans. 1, 1980, 1139–1146
28. For one of the first applications of peptidic α-keto esters as protease inhibitors, see:Hori, H.; Yasutake, A.; Minematsu, Y.; Powers, J. C. Inhibition of Human Leukocyte Elastase, Porcine Pancreatic Elastase and Cathepsin G by Peptide Ketones. In Peptides Structure and Function; Proceedings of the Ninth American Peptide Symposium; Deber, C. M., Hruby, V. J., Kopple, K. D., Eds.; 1985; pp 819–822.
29. Application of α-hydroxy ester based peptides as renin inhibitors was reported right after our own work was completed. See: (a)Iizuka, K.; Kamijo, T.; Kubota, T.; Akahane, K.; Umeyama, H.; Kiso, Y. New Human Renin Inhibitors Containing an Unnatural Amino Acid, Norstatine. J. Med. Chem. 1988, 31, 701–704.
30. Iizuka, K.; Kamijo, T.; Harada, H.; Akahane, K.; Kubota, T.; Umeyama, H.; Kiso, Y. Orally Potent Human Renin Inhibitors Derived from Angiotensinogen Transition State: Design, Synthesis, and Mode of Interaction. J. Med. Chem. 1990, 33, 2707–2714.
31. Seebach, D. Metalated Orthothioformates. Angew. Chem., Int. Ed. Engl. 1967, 6, 442–443.
32. Damon, R. E.; Luo, T.; Schlessinger, R. H. A General Synthesis of 2-Alkyl Tetronic Acids. Tetrahedron Lett. 1976, 32, 2749–2752.
33. D. Seebach. Chem. Ber. 1972, 105, 487–510.
34. Ellison, R. A.; Woessner, W. D.; Williams, C. C. New Synthetic Methods from Dithianes. A Convenient Oxidation of Aldehydes to Acids and Esters. J. Org. Chem. 1972, 37, 2757–2759.
35. Ellison, R. A.; Woessner, W. D.; Williams, C. C. Hydrolysis and Alcoholysis of Orthothio Esters. J. Org. Chem. 1974, 39, 1430–1433.
36. Dailey, O. D., Jr.; Fuchs, P. L. Synthesis of a Model for the BCE Ring System of Bruceantin. A Caveat on the Cyclohexene -> Trans Diaxial Diol Conversion. J. Org. Chem. 1980, 45, 216–236.
37. Hengeveld, J. E.; Grief, V.; Tadanier, J.; Lee, C.-M.; Riley, D.; Lartey, P. A. A General Synthesis of Methyl Aldulosonates Using Tris-(Methylthio) Methyl Lithium as the Ester Anion Equivalent. Tetrahedron Lett. 1984, 25, 4075–4078.
38. Rich, D. H.; Sun, E. T. O.; Ulm, E. Synthesis of Analogues of the Carboxyl Protease Inhibitor Pepstatin. Effect of Structure on Inhibition of Pepsin and Renin. J. Med. Chem. 1980, 23, 27–33.
39. Defour, M.; Jouin, P.; Poncet, J.; Pantalino, A.; Castro, B. Synthesis and Reduction of α-Amino Ketones Derived from Leucine. J. Chem. Soc., Perkin Trans. 1 1986, 1895–1899
40. Cardillo, G.; Orena, M.; Sandri, S.; Tamasini, C. Synthesis of Oxazolidin-2-ones Using Carbonate Ion on a Polymeric Support. Tetrahedron 1985, 41, 163–167.
41. For preparation of 29, see:Weller, H. N. III; Ryono, D. E. US Patent 5,055,466.
42. 2) in Renin Inhibitors. J. Org. Chem. 1990, 55, 1679–1682.
43. A very similar route for preparing peptidyl α-keto esters was reported in the literature after the completion of our own work. See:Burkhart, J. P.; Peet, N. P.; Bey, P. A Novel Method for the Preparation of Peptidyl α-Keto Esters. Tetrahedron Lett. 1990, 31, 1385–1388. Their synthesis also lead to an epimeric mixture of α-keto esters; however, racemization in their case was claimed to occur directly during swern oxidation of the chiral α-hydroxy ester intermediate.
44. Salamone, S. J.; Jordan, F. Synthesis of 9-(3,4-Dioxopentyl)hypoxanthine, the First Arginine-Directed Purine Derivative: An Irreversible Inactivator for Purine Nucleoside Phosphorylase. Biochemistry 1982, 21, 6383–6388.
45. Angelastro, M. R.; Peet, N. P.; Bey, P. An Efficient Synthesis of Novel α-Diketone and α-Keto Ester Derivatives of N-Protected Amino Acids and Peptides. J. Org. Chem. 1989, 54, 3913–3916.
46. Seebach, D.; Corey, B. J. Generation and Synthetic Applications of 2-Lithio-1,3-dithianes. J. Org. Chem. 1975, 40, 231–237.
47. Seebach, D.; Welka, E-M. Alkylation of 2-Lithio-1,3-dithianes with Arenesulfonates of Primary Alcohols. Synthesis 1976, 476–477
48. For a review of stereoselective synthesis of β-amino alcohols from α-amino aldehydes, see:Jurczak, J.; Golebiowski, A. Optically Active N-Protected α-Amino Aldehydes in Organic Synthesis. Chem. Rev. 1989, 89, 149–164.
49. Also see:Reetz, M. T.; Drewes, M. W.; Schmitz, A. Stereoselective Synthesis of β-Amino Alcohols from Optically Active α-Amino Acids. Angew. Chem., Int. Ed. Engl. 1987, 26, 1141–1143.
50. Ho, T.-L.; Ho, H. C.; Wong, C. M. Dethioacetalisation with Ceric Ammonium Nitrate. J. Chem. Soc., Chem. Comm. 1972, 791.
51. Ho, T.-K. Ceric Ion Oxidation in Organic Chemistry. Synthesis 1973, 347–354
52. Cristau, H.-J.; Chabaud, B.; Labaudiniere, R.; Christol, H. Removal of Thioacetal Protecting Groups by Cerium (IV) Ammonium Nitrate - Hydrolysis of 1,3-Dithiannes. Synth. Commun. 1981, 11, 423–428.
53. Fujita, E.; Nagao, Y.; Kaneko, K. Useful Dethioacetalization with Soft Acid Metal Salts: Thallium Trinitrate and Mercuric Perchlorate. Chem. Pharm. Bull. 1978, 26, 3743–3751.
54. im-Tosyl-l-histidine. Bull. Chem. Soc. 1969, 42, 1466.
55. im-Tosylhistidine Derivatives as Starting Materials. Bull. Chem. Soc. 1974, 47, 3146–3151.
56. Yamada, S.; Kasai, Y.; Shioiri, T. Diethylphosphoryl Cyanide. A New Reagent for the Synthesis of Amides. Tetrahedron Lett. 1973, 14, 1595–1598.
57. Sham, H. L.; Stein, H.; Rempel, C. A.; Cohen, J.; Plattner, J. B. Highly potent and specific inhibitors of human renin. FEBS Lett. 1987, 220, 299–301.
58. Thaisrivong, S.; Pals, D. T.; Kati, W. M.; Temer, S. R.; Thomasco, L. M. Difluorostatine- and Difluorostatone-Containing Peptides as Potent and Specific Renin Inhibitors. J. Med. Chem. 1985, 28, 1553–1555.
59. Thaisrivong, S.; Pals, D. T.; Kati, W. M.; Temer, S. R.; Thomasco, L. M.; Watt, W. Design and Synthesis of Potent and Specific Renin Inhibitors Containing Difluorostatine, Difluorostatone, and Related Analogues. J. Med. Chem. 1986, 29, 2080–2087.
60. Fearon, K.; Spaltenstein, A.; Hopkms, P. B.; Gelb, M. H. Fluoro Ketone Containing Peptides as Inhibitors of Human Renin. J. Med. Chem. 1987, 30, 1617–1622.
61. Tarnus, C.; Jung, M. J.; Remy, J.-M., Baltzer, S.; Schirlin, D. G. New fluoroketones as human renin inhibitors. FEBS Lett. 1989, 249, 47–50.
62. Boger, J.; Lohr, N. S.; Ulm, E. H.; Poe, M.; Blaine, E. H.; Fanelli, G. M.; Lin, T.-Y.; Payne, L. S.; Schorn, T. W.; Lamont, B. I.; Vassil, T. C.; Stabilito, I.I.; Veber, D. F.; Rich, D. H.; Bopari, A. S. Novel renin inhibitors containing the amino acid statine. Nature (London) 1983, 303, 81–84.
63. Angelastro, M. R.; Mehdi, S.; Burkhart, J. P.; Peet, N. P.; Bey, P. α-Diketone and α-Keto Ester Derivatives of N-Protected Amino Acids and Peptides as Novel Inhibitors of Cysteine and Serine Proteinases. J. Med. Chem. 1990, 33, 11–13.